These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 24684070

  • 1. [New method for treatment of chronic blepharitis associated with dry eye syndrome].
    Safonova TN, Zabegaĭlo AO, Fedorov AA, Lukisheva OV.
    Vestn Oftalmol; 2014; 130(1):73-8. PubMed ID: 24684070
    [Abstract] [Full Text] [Related]

  • 2. An evaluation of the efficacy of a cyclosporine-based dry eye therapy when used with marketed artificial tears as supportive therapy in dry eye.
    Sall KN, Cohen SM, Christensen MT, Stein JM.
    Eye Contact Lens; 2006 Jan; 32(1):21-6. PubMed ID: 16415689
    [Abstract] [Full Text] [Related]

  • 3. Dry eye, blepharitis and chronic eye irritation: divide and conquer.
    Gilbard JP.
    J Ophthalmic Nurs Technol; 1999 Jan; 18(3):109-15. PubMed ID: 10633658
    [Abstract] [Full Text] [Related]

  • 4. [Use of cyclosporine 0.05% in various ocular surface disorders].
    Maĭchuk DIu, Vasil'eva OA, Shokirova MM.
    Vestn Oftalmol; 2014 Jan; 130(2):68-71. PubMed ID: 24864503
    [Abstract] [Full Text] [Related]

  • 5. Current evidence for topical azithromycin 1% ophthalmic solution in the treatment of blepharitis and blepharitis-associated ocular dryness.
    Veldman P, Colby K.
    Int Ophthalmol Clin; 2011 Jan; 51(4):43-52. PubMed ID: 21897139
    [No Abstract] [Full Text] [Related]

  • 6. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years.
    Barber LD, Pflugfelder SC, Tauber J, Foulks GN.
    Ophthalmology; 2005 Oct; 112(10):1790-4. PubMed ID: 16102833
    [Abstract] [Full Text] [Related]

  • 7. Reversibility of dry eye deceleration after topical cyclosporine 0.05% withdrawal.
    Rao SN.
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):603-9. PubMed ID: 21999340
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. When eyes get dry and what you can try. If artificial tears didn't work, anti-inflammatory cyclosporine drops may.
    Harv Health Lett; 2010 Oct; 35(12):4-6. PubMed ID: 21089264
    [No Abstract] [Full Text] [Related]

  • 11. [Efficacy of lid hygiene in treatment of patients with blepharoconjunctival form of dry eye syndrome].
    Polunin GS, Zabegaĭlo AO, Makarov IA, Safonova TN, Polunina EG.
    Vestn Oftalmol; 2012 Oct; 128(1):37-40. PubMed ID: 22741294
    [Abstract] [Full Text] [Related]

  • 12. Integrating restasis into the management of dry eye.
    Pflugfelder SC.
    Int Ophthalmol Clin; 2006 Oct; 46(4):101-3. PubMed ID: 17060796
    [No Abstract] [Full Text] [Related]

  • 13. Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment.
    Wilson SE, Perry HD.
    Ophthalmology; 2007 Jan; 114(1):76-9. PubMed ID: 17070588
    [Abstract] [Full Text] [Related]

  • 14. [Calcinosis conjunctivae in chronic blepharitis].
    Auw-Hädrich C, Reinhard T.
    Klin Monbl Augenheilkd; 2008 Jan; 225(1):101-2. PubMed ID: 18236381
    [Abstract] [Full Text] [Related]

  • 15. Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis.
    Salib GM, McDonald MB, Smolek M.
    J Cataract Refract Surg; 2006 May; 32(5):772-8. PubMed ID: 16765793
    [Abstract] [Full Text] [Related]

  • 16. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production.
    Pflugfelder SC, De Paiva CS, Villarreal AL, Stern ME.
    Cornea; 2008 Jan; 27(1):64-9. PubMed ID: 18245969
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and Safety of Topical Atorvastatin for the Treatment of Dry Eye Associated with Blepharitis: A Pilot Study.
    Ooi KG, Wakefield D, Billson FA, Watson SL.
    Ophthalmic Res; 2015 Jan; 54(1):26-33. PubMed ID: 26068735
    [Abstract] [Full Text] [Related]

  • 18. Effects of topical cyclosporine a plus artificial tears versus artificial tears treatment on conjunctival goblet cell density in dysfunctional tear syndrome.
    Demiryay E, Yaylali V, Cetin EN, Yildirim C.
    Eye Contact Lens; 2011 Sep; 37(5):312-5. PubMed ID: 21792057
    [Abstract] [Full Text] [Related]

  • 19. [Evaluation of NAAGA efficacy in dry eye syndrome].
    Brignole-Baudouin F, Robert PY, Creuzot-Garcher C, Olmiere C, Delval L, Baudouin C.
    J Fr Ophtalmol; 2009 Nov; 32(9):613-20. PubMed ID: 19854539
    [Abstract] [Full Text] [Related]

  • 20. Ophthalmic cyclosporine use in ocular GVHD.
    Lelli GJ, Musch DC, Gupta A, Farjo QA, Nairus TM, Mian SI.
    Cornea; 2006 Jul; 25(6):635-8. PubMed ID: 17077652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.